Insider · CIK 0001903781
Hayon Igal Louria
Files at RAPH (Raphael Pharmaceutical Inc.). First filing -, latest -.
In brief
Hayon Igal Louria files SEC Form 4 as officer and director at RAPH (Raphael Pharmaceutical Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Hayon Igal Louria has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | RAPH Raphael Pharmaceutical Inc. | XIn-the-money exercise Common Stock | +350,000 | $0.01 | $3,500 | 1,349,000 | Apr 6, 2026 |
| Nov 20, 2025 | RAPH Raphael Pharmaceutical Inc. | XIn-the-money exercise Warrants to purchase Common Stockderivative | -350,000 | - | - | 0 | Apr 6, 2026 |
| Aug 29, 2023 | RAPH Raphael Pharmaceutical Inc. | XIn-the-money exercise Common Stock | +999,000 | $0.01 | $9,990 | 999,000 | Mar 25, 2024 |
| Aug 29, 2023 | RAPH Raphael Pharmaceutical Inc. | XIn-the-money exercise Warrants to purchase Common Stockderivative | -999,000 | - | - | 0 | Mar 25, 2024 |
Questions about Hayon Igal Louria
Answered from the filings on this page, as of the latest one.
Is Hayon Igal Louria buying or selling?
Hayon Igal Louria has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Hayon Igal Louria's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Hayon Igal Louria has 0.
Where does Hayon Igal Louria file Form 4?
Hayon Igal Louria has filed Form 4 at RAPH (Raphael Pharmaceutical Inc.) as Chief Technology Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.